Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients

Sang-Wan CHUNG; In-Seol YOO; Jinhyun KIM; Seong-Wook KANG; Mihye KWON; Chung-Il JOUNG; In-Ah CHOI; Sung-Hae CHANG; Mi-Il KANG; Seung-Jae HONG; Yeon-Ah LEE.
Yonsei Medical Journal ; : 424-430, 2021.
Artículo en Inglés | WPRIM | ID: wpr-896560

Documentos relacionados

  1. Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients.
  2. Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients
  3. Efficacy and tolerance of corticosteroids and methotrexate in patients with juvenile dermatomyositis: a retrospective cohort study.
  4. Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria in Patients With Idiopathic Inflammatory Myopathy and Anti-Melanoma Differentiation-Associated Protein 5 Positivity.
  5. Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review.
  6. Dermatomyositis: Muscle Pathology According to Antibody Subtypes.
  7. Inflammatory myopathies: an update for neurologists.
  8. Anti-signal recognition particle positive necrotizing myopathy-sjogren's syndrome overlap syndrome: a descriptive study on clinical and myopathology features.
  9. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
  10. The diagnostic value of urinary N-terminal fragment of titin for skeletal muscle damage in idiopathic inflammatory myopathy.